Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion
AssigneeForest Laboratories Holdings Limited
InventorsJeffrey Jonas, Anjana Bose, Joyce Tsai
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of treating a central nervous system disorder, such as a mood disorder (e.g., major depressive disorder) or an anxiety disorder (e.g., general anxiety disorder, social anxiety disorder, post traumatic stress disorder, and panic disorder) with a low dose combination of escitalopram and bupropion.
Claims6
1-10. (canceled)
A method for treating sexual dysfunction in a patient suffering from sexual dysfunction due to treatment with an antidepressant other than a combination of escitalopram or a pharmaceutically acceptable salt thereof and bupropion or a pharmaceutically acceptable salt thereof, comprising:
- (a) discontinuing treatment with the antidepressant;
- and
- (b) administering daily to the patient an effective amount of bupropion or a pharmaceutically acceptable salt thereof in an amount up to about 225 mg, and an effective amount of escitalopram or a pharmaceutically acceptable salt thereof in an amount up to about 20 mg.
(canceled)
Dependencies are inferred from the claim text.